# Useful care can start before you pay for a procedure *Joint Pain Treatment Peoria | Care Before Paying Yourself* > Joint pain treatment Peoria choices before you pay the whole bill, including home care, exercise, medicine, and surgery alternatives. Which care makes sense before you pay for a joint procedure? An exam, easy movement, and medicine often come before a shot. You won’t need every choice on the same day. A hot, swollen joint needs prompt medical care first. ## The exam comes before the treatment choice The doctor asks where you hurt and when the soreness began. Your joint is checked for warmth, swelling, strength, and movement. Mention an old injury, new medicine, numbness, weakness, fever, or a fall. Those details help the doctor choose care for the right cause. ## Easy movement often belongs in early care Gentle exercise can help you keep strength and motion. More isn’t always better when soreness suddenly gets worse. Choose movements that don’t leave the joint hurting more afterward. A physical therapist can change the exercise if pain stays worse. ## Medicine has to fit the rest of your health Common pain pills aren’t safe for everyone. Your heart, kidneys, stomach, and other medicines can change the choice. Ordinary pain cream may suit a knee or hand just beneath the skin. Ask your doctor how long to use it and when to stop. ## Surgery alternatives still need a reason from the exam After an exam, QC Kinetix offers regenerative treatments such as PRP, a joint shot prepared by concentrating platelets from your own blood. Some people consider these as knee or hip surgery alternatives. Can surgery always be avoided? It can’t when severe damage keeps the joint from working well. Most people ask whether a shot must come first. It doesn’t; exercise, therapy, and medicine may come before it. Ask how well surgery may ease soreness and how hard recovery may be. Then compare that answer with the shot, therapy, medicine, and home care. ## Sources 1. OARSI's 2019 guideline is the only major osteoarthritis guideline that grades treatments separately for people with disease in MULTIPLE joints. Its Core Treatments for polyarticular OA are arthritis education and structured land-based exercise. Critically, intra-articular corticosteroid and intra-articular hyaluronic acid were Level 1B/2 options for knee OA only and were NOT recommended for hip or polyarticular OA; oral NSAIDs were not recommended at all for people with cardiovascular comorbidity or frailty; and paracetamol/acetaminophen was conditionally not recommended. Bannuru RR, Osani MC, Vaysbrot EE, et al. — [OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/31278997/). *Osteoarthritis and Cartilage*, 2019. DOI: 10.1016/j.joca.2019.06.011. 2. A Cochrane overview of 21 systematic reviews (381 studies, 37,143 participants) covering rheumatoid arthritis, osteoarthritis, fibromyalgia, low back pain, neck disorder and other chronic pain conditions concluded that physical activity and exercise are interventions with few adverse events that may improve pain severity and physical function - but that the quality of the evidence is low, effects on pain were inconsistent across reviews, and physical function improved significantly in 14 reviews with only small-to-moderate effect sizes. The commonest reported adverse event was increased muscle soreness that settled within weeks. Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH — [Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.](https://pubmed.ncbi.nlm.nih.gov/28436583/). *Cochrane Database of Systematic Reviews*, 2017. DOI: 10.1002/14651858.CD011279.pub3. 3. A systematic review and meta-analysis of five US retrospective studies comparing direct access to physical therapy against physician-first referral for musculoskeletal disorders found reduced physical therapy costs (d = -0.23, 95% CI -0.35 to -0.11) and reduced total health care costs (d = -0.19) with direct access, alongside improved or equivalent functional outcomes and fewer visits. Hon S, Ritter R, Allen DD — [Cost-Effectiveness and Outcomes of Direct Access to Physical Therapy for Musculoskeletal Disorders Compared to Physician-First Access in the United States: Systematic Review and Meta-Analysis.](https://pubmed.ncbi.nlm.nih.gov/33245117/). *Physical Therapy*, 2021. DOI: 10.1093/ptj/pzaa201. 4. In the PEAK non-inferiority randomised trial, 394 Australian adults with chronic knee pain were randomised to five physiotherapy consultations over 3 months delivered either in person or by video conference. Both groups improved (mean pain change 2.98 in person, 3.14 by video), and telerehabilitation was non-inferior for pain (mean difference 0.16, 95% CI -0.26 to 0.57) and function (1.65, -0.23 to 3.53). Adverse events were similar (21% vs 19%) and none were serious. Hinman RS, Campbell PK, Lawford BJ, et al. — [Telerehabilitation consultations with a physiotherapist for chronic knee pain versus in-person consultations in Australia: the PEAK non-inferiority randomised controlled trial.](https://pubmed.ncbi.nlm.nih.gov/38461844/). *The Lancet*, 2024. DOI: 10.1016/S0140-6736(23)02630-2. 5. In a randomized trial of 156 US Military Health System primary-care patients with knee osteoarthritis, physical therapy beat glucocorticoid injection at one year: mean WOMAC total scores were 37.0 with physical therapy versus 55.8 with injection (mean between-group difference 18.8 points, 95% CI 5.0 to 32.6, lower is better), with secondary outcomes in the same direction. Deyle GD, et al. — [Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee.](https://pubmed.ncbi.nlm.nih.gov/32268027/). *N Engl J Med*, 2020. DOI: 10.1056/NEJMoa1905877. 6. FDA states verbatim that of the products marketed as regenerative medicine - stem cell products, stromal vascular fraction from adipose tissue, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products - 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells from umbilical cord blood, approved only for disorders of blood production, and there are currently no FDA-approved exosome products. U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA (Center for Biologics Evaluation and Research)*, 2024. 7. A 2025 Cochrane living review of 25 randomised trials (1,341 participants) found that compared with placebo injection, stem cell injections for knee osteoarthritis MAY slightly improve pain and function up to six months, on LOW-certainty evidence: mean pain was 4.5 of 10 with placebo and 1.2 points better with stem cells; function 46.3 of 100 with placebo and 14.2 points better. Certainty was downgraded for indirectness (source, preparation and dose of cells varied across studies) and suspected publication bias - up to three larger trials were conducted and then withdrawn before reporting. Radiographic progression was not assessed in ANY included study, and the review remains uncertain about harms. Whittle SL, Johnston RV, McDonald S, et al. — [Stem cell injections for osteoarthritis of the knee.](https://pubmed.ncbi.nlm.nih.gov/40169165/). *Cochrane Database of Systematic Reviews*, 2025. DOI: 10.1002/14651858.CD013342.pub2. 8. A meta-analysis of 198 randomised osteoarthritis trials (16,364 patients in placebo groups, 1,167 in untreated control groups) found the placebo arm itself relieved pain with an effect size of 0.51 (95% CI 0.46-0.55), against 0.03 (95% CI -0.13 to 0.18) in untreated controls. Placebo also improved function and stiffness. The placebo effect was larger when the active treatment effect was larger, when baseline pain was higher, and - relevant to any injected treatment - when the placebo was delivered by injection rather than by mouth. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M — [The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials.](https://pubmed.ncbi.nlm.nih.gov/18541604/). *Annals of the Rheumatic Diseases*, 2008. DOI: 10.1136/ard.2008.092015. ## Your questions can come to the visit The Peoria office can review your soreness, past care, and daily needs. Call (602) 837-PAIN to ask how long the visit takes and what to bring. Book a free consultation: --- Help for a sore joint. Straight answers about joint soreness, care at home, warning signs, costs, and nearby treatment choices in Peoria. Plain Peoria help for one sore joint and the care choices ahead. This site is operated by the same owners who run QC Kinetix clinics across the Phoenix area, so that group may benefit when a reader schedules with those offices. © 2026 The Peoria Joint Board. General education only; a clinician who examines you should guide personal medical decisions.